Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Touchstone International Medical Science Co's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 16.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SHSE:688013's 5-Year ROIIC % is ranked better than 71.04% of 732
companies
in the Medical Devices & Instruments industry
Industry Median: 0.87
vs SHSE:688013: 16.80
Touchstone International Medical Science Co (SHSE:688013) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Touchstone International Medical Science Co 5-Year ROIIC % Related Terms
Touchstone International Medical Science Co 5-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co 5-Year ROIIC % Chart
Touchstone International Medical Science Co Annual Data
SHSE:688013 vs ISRG, BDX, MDLN: 5-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touchstone International Medical Science Co 5-Year ROIIC % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Touchstone International Medical Science Co (SHSE:688013) has a 5-Year ROIIC % of 16.80 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Touchstone International Medical Science Co and its competitors. According to the industry distribution chart, Touchstone International Medical Science Co ranks #212 out of 732 companies in the Medical Devices & Instruments industry, placing it in the top 29%.
Is Touchstone International Medical Science Co's 5-Year ROIIC % too high?
Touchstone International Medical Science Co's current 5-Year ROIIC % is 16.80. The Medical Devices & Instruments industry median 5-Year ROIIC % is 0.87. Touchstone International Medical Science Co's value of 16.80 is 1831% above this industry median. Based on the distribution chart, Touchstone International Medical Science Co ranks #212 out of 732 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Touchstone International Medical Science Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's 5-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #212 out of 732 companies for 5-Year ROIIC %. This puts Touchstone International Medical Science Co in the upper half of its industry. The industry median 5-Year ROIIC % is 0.87. Touchstone International Medical Science Co's value of 16.80 is 1831% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Devices & Instruments company?
The median 5-Year ROIIC % among Medical Devices & Instruments companies is 0.87, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current 5-Year ROIIC % of 16.80 is 1831% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year ROIIC % is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current 5-Year ROIIC % is 16.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.74, compared to a current price of ¥26.66 — trading 7.2% below its estimated fair value. The current 5-Year ROIIC % is 16.80 and 1831% above the Medical Devices & Instruments industry median of 0.87. Touchstone International Medical Science Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current 5-Year ROIIC % is 16.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?
Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued.
The current stock price of ¥26.66 is trading 7.2% below its estimated GF Value™ of ¥28.74.
GuruFocus considers Touchstone International Medical Science Co to be Fairly Valued.
Key valuation signals for SHSE:688013:
5-Year ROIIC %: 16.80
GF Value™: ¥28.74 vs. price of ¥26.66 (7.2% below fair value)
Industry Position: 1831% above the Medical Devices & Instruments median (#212 of 732)
No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
84GF Score
Get the complete analysis for SHSE:688013
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688013 has been successfully added to your 
